This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Wei-Ming Kao: Innovator in Stem Cell Mobilization
Introduction
Wei-Ming Kao is an accomplished inventor based in New York, NY, recognized for his significant contributions to the field of stem cell research. With a focus on enhancing the mobilization of hematopoietic stem cells, Kao's innovative work stands to benefit various medical treatments.
Latest Patents
Kao holds a patent for "Methods and compositions for modulating the mobilization of stem cells". This groundbreaking invention discloses methods aimed at promoting or increasing the mobilization of hematopoietic stem cells from the bone marrow into the peripheral blood. Notably, his patent emphasizes the use of adrenergic agonists in combination with mobilization agents to enhance this process. These mobilization agents may function by decreasing the expression or activity of the chemokine CXCL12 or by blocking the CXCR4 receptor. The methods outlined in his patent could significantly impact the harvesting of stem cells, making them extremely beneficial for treating various diseases and conditions that require cell transplantation.
Career Highlights
Wei-Ming Kao is affiliated with the Mount Sinai School of Medicine, where he contributes to groundbreaking research in stem cell mobilization. His work not only highlights his individual capabilities but also embodies the spirit of innovation that characterizes the institution.
Collaborations
Throughout his career, Kao has worked alongside notable colleagues, including Michela Battista and Paul S. Frenette. These collaborations foster a dynamic environment of shared knowledge and discoveries, further enhancing the impact of their collective research efforts in the field of stem cell therapy.
Conclusion
Wei-Ming Kao’s contributions to the field of stem cell mobilization through his innovative patent showcase not only his inventiveness but also the potential for significant advancements in medical treatment. His work is indicative of a larger effort within the scientific community to improve therapeutic techniques and outcomes for patients in need of stem cell transplants.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
